Zendesk (ZEN.US), US software firm, surges over 50% in today's premarket trading following a Dow Jones report. According to the report, Zendesk is getting closer to reaching an agreement with private equity firms Hellman & Friedman and Permira. The deal will result in PE firms acquiring Zendesk. Dow Jones report does not offer any details but says that deal may be finalized within days. It comes around 2 weeks after Zendesk ended an unsuccessful bid to sell itself.
Zendesk (ZEN.US) has recently halted a drop at the $55.00 support zone marked with pandemic lows. Current premarket quotes point to an over 50% jump at the start of today's trading with stock opening near $89.00 mark. Note that this level lies within a medium-term resistance zone, marked with previous price reactions.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appSource: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.